Get the Stockscreener App
35.44
0.20%
-0.07
After Hours:
35.10
-0.34
-0.96%
Indivior Plc stock is traded at $35.44, with a volume of 2.52M.
It is down -0.20% in the last 24 hours and down -1.58% over the past month.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
See More
Previous Close:
$35.51
Open:
$35.52
24h Volume:
2.52M
Relative Volume:
1.04
Market Cap:
$4.43B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
3,544.00
EPS:
0.01
Net Cash Flow:
$-383.00M
1W Performance:
-0.81%
1M Performance:
-1.58%
6M Performance:
+134.08%
1Y Performance:
+193.13%
1-Day Range:
$33.76
$35.82
1-Week Range:
$33.76
$37.66
52-Week Range:
$7.62
$38.00
Indivior Plc Stock (INDV) Company Profile
Name
Indivior Plc
Sector
Phone
804-379-1090
Address
234 BATH ROAD, SLOUGH, BERKSHIRE
Compare INDV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
35.44 | 4.44B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
127.17 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.31 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.01 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
45.79 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Initiated | H.C. Wainwright | Buy |
| Jul-22-25 | Resumed | Jefferies | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-23-24 | Initiated | Piper Sandler | Overweight |
| Apr-03-24 | Initiated | Craig Hallum | Buy |
| Jul-13-23 | Initiated | Northland Capital | Outperform |
View All
Indivior Plc Stock (INDV) Latest News
Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance - Insider Monkey
Indivior (NasdaqGS:INDV) Valuation Check After Strong Long Term Returns And Recent Price Consolidation - Yahoo Finance UK
Indivior PLCOrdinary Shares (NQ: INDV - FinancialContent
Craig-Hallum raises Indivior stock price target to $50 on strong 2026 outlook - Investing.com Nigeria
Aug Closing: Why hedge funds are buying Indivior PLC stockWall Street Watch & Safe Entry Trade Signal Reports - moha.gov.vn
Can Indivior PLC stock double in next 5 years2025 Volume Leaders & Safe Entry Point Alerts - ulpravda.ru
Why Indivior PLC (2IVB) stock is a strong analyst pickWeekly Risk Summary & Safe Entry Point Identification - ulpravda.ru
Why retail investors pile into Indivior PLC stockJuly 2025 Momentum & Fast Moving Market Watchlists - ulpravda.ru
Is Indivior PLC stock a top pick in earnings season2025 Macro Impact & Fast Exit Strategy with Risk Control - ulpravda.ru
What margin trends mean for Indivior PLC stockWeekly Trade Report & Real-Time Chart Pattern Alerts - ulpravda.ru
GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug - Finviz
Published on: 2026-01-08 20:56:58 - ulpravda.ru
How Indivior PLC stock performs during Fed tightening cycles2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - ulpravda.ru
What analyst consensus says on Indivior PLC stock2025 AllTime Highs & Daily Technical Stock Forecast Reports - ulpravda.ru
Indivior Issues FY 2026 Financial Guidance - Nasdaq
Indivior shares rise after FY26 guidance tops consensus expectations By Investing.com - Investing.com Nigeria
Indivior PLC Provides Earnings Guidance for the Full Year 2026 - MarketScreener
Indivior Expects Up to $1.20 Billion in 2026 Net Revenue - MarketScreener
(INDV) Indivior Expects 2026 Revenue Range $1.13B$1.2B, vs. FactSet Est of $1.19B - MarketScreener
Indivior forecasts 11% SUBLOCADE growth, 35% EBITDA increase for 2026 By Investing.com - Investing.com South Africa
Indivior PLC Announces Full-Year 2026 Financial Guidance and Business Highlights - Quiver Quantitative
Indivior : Financial Document - MarketScreener
Indivior PLC Provides 2026 Financial Guidance and Business Update - TradingView — Track All Markets
Indivior Provides Full-Year 2026 Financial Guidance and Business Update - Bluefield Daily Telegraph
Indivior price target raised to $40 from $30 at Northland - MSN
Insider Buying: Barbara Ryan Acquires Shares of Indivior PLC - GuruFocus
Indivior director Stejbach buys $27,429 in shares By Investing.com - Investing.com UK
Ryan Barbara, Indivior director, buys $27,429 in shares By Investing.com - Investing.com UK
Wheadon David E., Indivior director, buys $62,680 in shares By Investing.com - Investing.com South Africa
Indivior director Ninivaggi buys $27,429 in shares By Investing.com - Investing.com Nigeria
Humphreys Keith buys Indivior (INDV) shares worth $27,429 By Investing.com - Investing.com South Africa
Humphreys Keith buys Indivior (INDV) shares worth $27,429 - Investing.com
Ryan Barbara, Indivior director, buys $27,429 in shares - Investing.com
Indivior director Ninivaggi buys $27,429 in shares - Investing.com
Indivior shareholders approve scheme of arrangement - MSN
Will Indivior PLC stock reach all time highs in 20252026 world cup usa national team quarterfinals defensive leaders low block defense match prediction insights - ulpravda.ru
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations - Eastern Progress
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table - AOL.com
Indivior outlines $1.03B–$1.08B 2025 revenue guidance and cost structure overhaul through action agenda - MSN
Suboxone Market is Going to Booming Growth 2025 With Top Key - openPR.com
Indivior PLC stock: volatile swings, legal overhangs and a nervous market mood - AD HOC NEWS
(INDV) Risk Channels and Responsive Allocation - Stock Traders Daily
Aug Opening: How Indivior PLC 2IVB stock responds to job market shiftsPortfolio Return Summary & Target Return Focused Stock Picks - moha.gov.vn
Daily Penny AlertsIndivior PLCOrdinary Shares (Nasdaq:INDV) Stock Quote - FinancialContent
Indivior PLC: Opioid-treatment specialist tests investor nerves as volatility returns - AD HOC NEWS
Indivior PLC (INDV) Stock Price History & Data - Traders Union
What’s next for Indivior after a 200% run? Jefferies eyes 2026 upside - Investing.com
Indivior (NasdaqGS:INDV): Revisiting Valuation After S&P SmallCap 600 Inclusion and Strong Recent Share Price Gains - Yahoo Finance
Does S&P SmallCap 600 Inclusion Refocus Indivior’s (INDV) Story Around Its SUBLOCADE Franchise? - Yahoo Finance
Is It Too Late To Consider Indivior After Its 191.6% Surge In 2025? - Yahoo Finance
Indivior Announces Inclusion in the S&P SmallCap 600® Index - Sahm
Indivior Plc Stock (INDV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Indivior Plc Stock (INDV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Humphreys Keith | Director |
Jan 05 '26 |
Buy |
35.39 |
775 |
27,429 |
5,802 |
| NINIVAGGI DANIEL A | Director |
Jan 05 '26 |
Buy |
35.39 |
775 |
27,429 |
16,923 |
| Stejbach Mark | Director |
Jan 05 '26 |
Buy |
35.39 |
775 |
27,429 |
16,847 |
| Wheadon David E. | Director |
Jan 05 '26 |
Buy |
35.39 |
1,771 |
62,680 |
14,395 |
0.37%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):